Table 3 Quality assessment by anthropometric and morbidity outcomes
From: Effectiveness of Micronutrient Powders (MNP) in women and children
Stunting: Moderate outcome specific quality of evidence | ||||||||
|---|---|---|---|---|---|---|---|---|
Two study (three data sets) | RCT | No significant heterogeneity, fixed effect model used | None of the study suggests benefit | All studies from the developing countries | Â | 810 | 838 | RR: 0.92 [0.81, 1.04] |
Wasting: Moderate outcome specific quality of evidence | ||||||||
Two study (three data sets) | RCT | No significant heterogeneity, fixed effect model used | None of the study suggests benefit | All studies from the developing countries | Â | 263 | 234 | RR: 1.13 [0.91, 1.40] |
Underweight: Moderate outcome specific quality of evidence | ||||||||
Three studies (four data sets) | RCT | No significant heterogeneity, fixed effect model used | None of the studies suggest significant benefit | All the studies from developing countries | All studies included more than 3 micronutrients. The studies ranged in duration from 4-12 months. | 671 | 679 | RR: 0.96 [0.83, 1.10] |
HAZ: Moderate outcome specific quality of evidence | ||||||||
Three | RCT | No significant heterogeneity, fixed effect model used | None of the studies suggest significant benefit | All studies are from Africa | All studies included more than 3 micronutrients. The studies ranged in duration from 6-12 months. | 271 | 253 | SMD: 0.04 [-0.13, 0.22] |
WAZ: Moderate outcome specific quality of evidence | ||||||||
Three | RCT | No significant heterogeneity, fixed effect model used | None of the studies suggest significant benefit | All studies from Africa | All studies included more than 3 micronutrients. The studies ranged in duration from 6-12 months. | 271 | 253 | SMD: 0.05 [-0.12, 0.23] |
WHZ: Moderate outcome specific quality of evidence | ||||||||
Three | RCT | No significant heterogeneity, fixed effect model used | None of the studies suggest significant benefit | All studies from Africa | All studies included more than 3 micronutrients. The studies ranged in duration from 6-12 months. | 271 | 253 | SMD: 0.04 [-0.13, 0.21] |
Diarrhea: Moderate outcome specific quality of evidence | ||||||||
Four studies (five data sets) | RCT | No significant heterogeneity, fixed effect model used | Direction of evidence is consistent across studies | All the studies from developing countries | Number of micronutrients ranged from 5-15. Duration varied from 2-12 months. One of the studies targeted children in school. | 1692 | 1679 | RR: 1.04 [1.01, 1.06] |
Recurrent Diarrhea: Moderate outcome specific quality of evidence | ||||||||
One | RCT | Only one study | Â | Study was conducted in Cambodia | Study was conducted over a 12 month period | 1 | 0 | RR: 2.86 [0.12, 69.00] |
URI: Moderate outcome specific quality of evidence | ||||||||
Two | RCT | No significant heterogeneity, fixed effect model used | None of the studies suggest benefit | All the studies from developing countries | Number of micronutrients ranged from 5-14. Duration varied from 8-12 months. One of the studies targeted children in school. | 30 | 26 | RR: 1.17 [0.71, 1.92] |
Fever: Moderate outcome specific quality of evidence | ||||||||
One | RCT | Only one study | Â | Study was conducted in India | Â | 41 | 41 | RR: 1.03 [0.70, 1.51] |